Skip to content
healthcare.dev
Get a free key

EMRELIS

NDC 0074-1055, Telisotuzumab Vedotin, injection, powder, lyophilized, for solution, from AbbVie Inc..

Product NDC
0074-1055
Status
Listed
Labeler
AbbVie Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761384
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0074-1055 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TELISOTUZUMAB VEDOTIN100 mg/mL
Package NDCNDC-11Package
0074-1055-01000741055011 VIAL, SINGLE-DOSE in 1 CARTON (0074-1055-01) / 1 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/bc04f980-3957-4e35-ab81-8ec2ffe87215

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0074-1055

Use it

Look up 0074-1055 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0074-1055 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0074-1055. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.